Propofol Modulates Gallbladder Cancer Progression via miR-4430/SLC19A3 Axis

Area of Science:

• Oncology
• Molecular Biology
• Anesthesiology

Background:

• Gallbladder cancer (GBC) is a significant health concern.
• MicroRNA (miRNA), specifically miR-4430, is a key factor in GBC research.
• Propofol, a widely used anesthetic, is investigated for its potential role in GBC regulation.

Purpose of the Study:

• To investigate the regulatory role of propofol in GBC.
• To elucidate the involvement of the miR-4430/SLC19A3 axis in propofol's effects on GBC.
• To determine if propofol modulates GBC cell behavior via this specific molecular pathway.

Main Methods:

• Utilized human GBC cell lines (NOZ and SGC996).
• Treated cells with propofol and measured miR-4430 and SLC19A3 expression via qRT-PCR.
• Assessed cell viability, migration, and apoptosis using colony formation, wound healing, and flow cytometry assays.
• Confirmed the miR-4430 and SLC19A3 interaction using dual-luciferase reporter assay.

Main Results:

• Propofol significantly repressed GBC cell proliferation (P = .025).
• miR-4430 expression reversed propofol's inhibitory effects.
• SLC19A3 was identified as a direct target of miR-4430, and its silencing reversed propofol-induced GBC cell alterations (P = .019).
• Overexpression of SLC19A3 attenuated proliferation and migration in propofol-treated GBC cells (P = .034).

Conclusions:

• Propofol exerts its effects on GBC cell behavior by modulating the miR-4430/SLC19A3 axis.
• This pathway represents a potential therapeutic target for GBC.